154 related articles for article (PubMed ID: 32984003)
1. CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer.
Lu T; Zhang L; Zhu W; Zhang Y; Zhang S; Wu B; Deng N
Front Oncol; 2020; 10():1529. PubMed ID: 32984003
[TBL] [Abstract][Full Text] [Related]
2. Succinate dehydrogenase subunit B inhibits the AMPK-HIF-1α pathway in human ovarian cancer in vitro.
Chen L; Liu T; Zhang S; Zhou J; Wang Y; Di W
J Ovarian Res; 2014 Dec; 7():115. PubMed ID: 25491408
[TBL] [Abstract][Full Text] [Related]
3. miR-6086 inhibits ovarian cancer angiogenesis by downregulating the OC2/VEGFA/EGFL6 axis.
Wu B; Zhang L; Yu Y; Lu T; Zhang Y; Zhu W; Song Q; Lv C; Guo J; Tian Y; Deng N
Cell Death Dis; 2020 May; 11(5):345. PubMed ID: 32393810
[TBL] [Abstract][Full Text] [Related]
4. Knockout of
Zhu W; Liu C; Lu T; Zhang Y; Zhang S; Chen Q; Deng N
Front Oncol; 2020; 10():1451. PubMed ID: 32983976
[TBL] [Abstract][Full Text] [Related]
5. Sensitization of Carboplatinum- and Taxol-Resistant High-Grade Serous Ovarian Cancer Cells Carrying p53, BRCA1/2 Mutations by Emblica officinalis (Amla) via Multiple Targets.
De A; De A; Sharma R; Suo W; Sharma M
J Cancer; 2020; 11(7):1927-1939. PubMed ID: 32194804
[No Abstract] [Full Text] [Related]
6. Long intergenic noncoding RNA LINC00284 knockdown reduces angiogenesis in ovarian cancer cells
Ruan Z; Zhao D
FASEB J; 2019 Nov; 33(11):12047-12059. PubMed ID: 31574234
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of
Cui Y; Wu BO; Flamini V; Evans BAJ; Zhou D; Jiang WG
Anticancer Res; 2017 Aug; 37(8):4415-4424. PubMed ID: 28739735
[TBL] [Abstract][Full Text] [Related]
8. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
Hao T; Huang S; Han F
Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional Regulation of Thrombospondins and Its Functional Validation through CRISPR/Cas9 Mediated Gene Editing in Corpus Luteum of Water Buffalo (Bubalus Bubalis).
Paul A; Bharati J; Punetha M; Kumar S; Mallesh VG; Chouhan VS; Sonwane A; Bag S; Bhure SK; Maurya VP; Singh G; Whitworth KM; Sarkar M
Cell Physiol Biochem; 2019; 52(3):532-552. PubMed ID: 30897320
[TBL] [Abstract][Full Text] [Related]
10. Role of BMI1 in epithelial ovarian cancer: investigated via the CRISPR/Cas9 system and RNA sequencing.
Zhao Q; Qian Q; Cao D; Yang J; Gui T; Shen K
J Ovarian Res; 2018 Apr; 11(1):31. PubMed ID: 29685168
[TBL] [Abstract][Full Text] [Related]
11. SPOCD1 accelerates ovarian cancer progression and inhibits cell apoptosis via the PI3K/AKT pathway.
Liu D; Yang Y; Yan A; Yang Y
Onco Targets Ther; 2020; 13():351-359. PubMed ID: 32021280
[TBL] [Abstract][Full Text] [Related]
12. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
13. FBXW7 inhibits invasion, migration and angiogenesis in ovarian cancer cells by suppressing VEGF expression through inactivation of β-catenin signaling.
Zhong L; Pan Y; Shen J
Exp Ther Med; 2021 May; 21(5):514. PubMed ID: 33791023
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-23a depletion promotes apoptosis of ovarian cancer stem cell and inhibits cell migration by targeting DLG2.
Zhuang RJ; Bai XX; Liu W
Cancer Biol Ther; 2019; 20(6):897-911. PubMed ID: 30862230
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of DEC1 inhibits proliferation, migration and invasion, and induces apoptosis in ovarian cancer cells via regulation of Wnt/β-catenin signaling pathway.
Yi Y; Liao B; Zheng Z; Yang X; Yang Y; Zhou Y; Tan B; Yang X
Exp Ther Med; 2021 Apr; 21(4):372. PubMed ID: 33732345
[TBL] [Abstract][Full Text] [Related]
16. CNOT7 modulates biological functions of ovarian cancer cells via AKT signaling pathway.
Yu J; Hu X; Chen X; Zhou Q; Jiang Q; Shi Z; Zhu H
Life Sci; 2021 Mar; 268():118996. PubMed ID: 33412213
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of long noncoding RNA-taurine-upregulated gene 1 inhibits tumor angiogenesis in ovarian cancer by regulating leucine-rich α-2-glycoprotein-1.
Fan M; Li C; He P; Fu Y; Li M; Zhao X
Anticancer Drugs; 2019 Jul; 30(6):562-570. PubMed ID: 30896502
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-506-3p inhibits proliferation and promotes apoptosis in ovarian cancer cell via targeting SIRT1/AKT/FOXO3a signaling pathway.
Xia XY; Yu YJ; Ye F; Peng GY; Li YJ; Zhou XM
Neoplasma; 2020 Mar; 67(2):344-353. PubMed ID: 31973537
[TBL] [Abstract][Full Text] [Related]
19. MiRNA-8073 targets ZnT1 to inhibit malignant progression of ovarian cancer.
Zhang L; Wang YH; Wang L
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6062-6069. PubMed ID: 31364107
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of RNA-Binding Protein Musashi-1 Suppresses Malignant Properties and Reverses Paclitaxel Resistance in Ovarian Carcinoma.
Chen H; Liu J; Wang H; Cheng Q; Zhou C; Chen X; Ye F
J Cancer; 2019; 10(6):1580-1592. PubMed ID: 31031868
[No Abstract] [Full Text] [Related]
[Next] [New Search]
